In a report released today, Thomas Blakey from Cantor Fitzgerald maintained a Hold rating on NICE (NICE – Research Report), with a price target of $161.00. The company’s share ...

Aerospace and defense corporation Rocket Lab USA (NASDAQ: RKLB) recently received a significant analyst boost when Cantor ...

It has been found in a phase I study that patients taking Eli Lilly's investigational obesity drug eloralintide lost more ...

Howard Lutnick called on Monday morning to pitch the “Trump Card”: a $5mn visa granting foreigners legal residency in the US. The US commerce secretary told the FT he had privately urged foreign ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: ...

The SkyBridge Capital founder is leaning into Solana’s “Ethereum killer” narrative—and going against Standard Chartered's ...

SOL Strategies, a Toronto-listed digital asset firm focused on Solana, filed with the U.S. Securities and Exchange Commission ...

Sol Strategies, a Solana Treasury firm, has filed Form 40-F with the U.S. SEC, seeking approval to list on the Nasdaq under ...

Sol Strategies is filing for a Nasdaq listing, aiming to boost its institutional investment, could propel Solana's price ...

In a report released today, Nur Cristiani from Morgan Stanley reiterated a Buy rating on NICE (NICE – Research Report), with a price target of $202.00. The company’s shares cl ...

SOL Strategies filed compliance documents with the SEC to get listed on the Nasdaq under the ticker symbol STKE.

The funding round included new investors such as NVentures, the venture capital arm of Nvidia Corp., and existing backers ...